Publications

Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro.

Robinson MK, Hodge KM, Horak E, Sundberg AL, Russeva M, Shaller CC, von Mehren M, Shchaveleva I, Simmons HH, Marks JD, Adams GP

British journal of cancer
. Oct 7, 2008
Development of human single-chain antibodies against SARS-associated coronavirus.

Leung KM, Feng DX, Lou J, Zhou Y, Fung KP, Waye MM, Tsui SK, Chan PK, Marks JD, Pang SF, Kan YW

Intervirology
. Aug 25, 2008
Effective treatment of established human breast tumor xenografts in immunodeficient mice with a single dose of the alpha-emitting radioisotope astatine-211 conjugated to anti-HER2/neu diabodies.

Robinson MK, Shaller C, Garmestani K, Plascjak PS, Hodge KM, Yuan QA, Marks JD, Waldmann TA, Brechbiel MW, Adams GP

Clinical cancer research : an official journal of the American Association for Cancer Research
. Feb 1, 2008
Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.

Smith TJ, Hill KK, Foley BT, Detter JC, Munk AC, Bruce DC, Doggett NA, Smith LA, Marks JD, Xie G, Brettin TS

PloS one
. Dec 5, 2007
Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy.

Fischer A, Garcia-Rodriguez C, Geren I, Lou J, Marks JD, Nakagawa T, Montal M

The Journal of biological chemistry
. Nov 20, 2007
Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells.

Roth A, Drummond DC, Conrad F, Hayes ME, Kirpotin DB, Benz CC, Marks JD, Liu B

Molecular cancer therapeutics
. Oct 1, 2007
Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction.

Turatti F, Figini M, Balladore E, Alberti P, Casalini P, Marks JD, Canevari S, Mezzanzanica D

Journal of immunotherapy (Hagerstown, Md. : 1997)
. Oct 1, 2007
Affinity thresholds for membrane fusion triggering by viral glycoproteins.

Hasegawa K, Hu C, Nakamura T, Marks JD, Russell SJ, Peng KW

Journal of virology
. Sep 5, 2007
Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen.

Tang Y, Lou J, Alpaugh RK, Robinson MK, Marks JD, Weiner LM

Journal of immunology (Baltimore, Md. : 1950)
. Sep 1, 2007
Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer.

Liu B, Conrad F, Roth A, Drummond DC, Simko JP, Marks JD

Journal of molecular medicine (Berlin, Germany)
. Jun 7, 2007